Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04788212 · ClinicalTrials.gov registry record · NA
Transdiagnostic Group Behavioral Activation for Autistic Adults
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04788212: Completed NA study, sponsored by Rutgers, The State University of New Jersey.
NCT04788212 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04788212, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults.
Primary Outcome
The ASR is a an assessment of adult psychopathology (e.g., anxiety, depression symptoms). Most of the items are on a 3 point scale including: (0) Not true, (1) Somewhat or sometimes true, and (2) Very often or often true.
Interventions
- BEHAVIORAL Group Behavioral Activation Therapy for Autism Spectrum Disorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2021-07-08 |
| Phase | NA |
What the finished NCT04788212 record still lists
NCT04788212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Group Behavioral Activation Therapy for Autism Spectrum Disorder is the first listed.
NCT04788212 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04788212 about?
NCT04788212 is a clinical study titled "Transdiagnostic Group Behavioral Activation for Autistic Adults". The purpose of this study is to evaluate the feasibility, acceptability and effectiveness of a telehealth Group Behavioral Activation Therapy (GBAT) for autistic adults.
What is the current status of trial NCT04788212?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2021-02-16. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT04788212?
The interventions under investigation include: Group Behavioral Activation Therapy for Autism Spectrum Disorder (BEHAVIORAL).
Who is sponsoring clinical trial NCT04788212?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04788212's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI